Active Pharmaceutical Ingredient (API)
Glibenclamide
Oral Antidiabetic (Sulfonylurea)
A potent sulfonylurea agent used to lower blood sugar in Type 2 Diabetes by stimulating insulin secretion from pancreatic $\beta$-cells. It is part of the second generation of sulfonylureas. Due to its strong effect, it carries a higher risk of hypoglycemia compared to modern alternatives like Metformin, and its use has declined in some regions.
Technical Profile
- Reference Code
- GLB044
- CAS Number
- 10238-21-8
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Glibenclamide as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Glinil M G | Cipla Limited | Tablet (5 mg) | ₹14.70 | View Details |
| Metafin 25/500 G | Advik Laboratories Ltd | Tablet (2.5 mg) | ₹75.00 | View Details |
| Glibimax-5 G | Unimax Laboratories | Tablet (5 mg) | ₹12.00 | View Details |